Severe asthma patients comprise about 3% to 13% of all asthma patients, but they have higher hospital utilization rates and higher medical costs than those of nonsevere asthma patients. Treatment methods for severe asthma patients are still lacking; however, the recent development of biologics is expected to have a positive effect. The biological therapies developed so far are mainly aimed at treating asthma patients with type 2 inflammation. These biologics have been found to reduce symptoms of asthma, improve lung function, reduce the use of oral corticosteroids, and improve quality of life of patients. This article reviews the mechanism of action and indications for approved biologics and discusses what should be considered when choosing biologics.
Citations
Citations to this article as recorded by
Current and Novel Biologic Therapies for Patients with Asthma and Nasal Polyps Hanna K. Mandl, Jessa E. Miller, Daniel M. Beswick Otolaryngologic Clinics of North America.2024; 57(2): 225. CrossRef
Moderate-High Blood Eosinophilia Is Associated with Increased Hospitalization and Other Asthma Comorbidities Sara Naharro-González, Clara Lorente-Sorolla, José Manuel Rodrigo-Muñoz, Marcela Valverde-Monge, Erwin Javier Pinillos-Robles, Diana Betancor, Mar Fernández-Nieto, Diana Sánchez-Mellado, Marta Gil-Martínez, Jessica Mireya Santillán-Coello, José Miguel Vil Biomolecules.2024; 14(1): 126. CrossRef
Biologic Therapies across Nasal Polyp Subtypes Kody G. Bolk, Sarah K. Wise Journal of Personalized Medicine.2024; 14(4): 432. CrossRef
Incremental net monetary benefit of biologic therapies in moderate to severe asthma: a systematic review and meta-analysis of economic evaluation studies Sajesh K. Veettil, Vanessa Vincent, Taylor Shufelt, Emma Behan, M. Sakil Syeed, Ammarin Thakkinstian, David C. Young, Nathorn Chaiyakunapruk Journal of Asthma.2023; 60(9): 1702. CrossRef
Tackling the cytokine storm using advanced drug delivery in allergic airway disease Vyoma K. Patel, Sukriti Vishwas, Rajan Kumar, Gabriele De Rubis, Shakti D. Shukla, Keshav Raj Paudel, Bikash Manandhar, Thakur Gurjeet Singh, Dinesh Kumar Chellappan, Monica Gulati, Indu Pal Kaur, Venkata Sita Rama Raju Allam, Philip M. Hansbro, Brian G. Journal of Drug Delivery Science and Technology.2023; 82: 104366. CrossRef
The evolving landscape of immunotherapy for the treatment of allergic conditions Aarti Pandya, Esosa Adah, Bridgette Jones, Rachel Chevalier Clinical and Translational Science.2023; 16(8): 1294. CrossRef
Effect of Dupilumab in Korean Patients With Uncontrolled Moderate-to-Severe Asthma: A LIBERTY ASTHMA QUEST Sub-analysis Chin Kook Rhee, Jung-Won Park, Heung-Woo Park, You Sook Cho Allergy, Asthma & Immunology Research.2022; 14(2): 182. CrossRef
The role of peripheral eosinophilia in diagnosing lung disorders: experience from a single pneumonological center Justyna Fijołek, Elzbieta Wiatr, Dorota Piotrowska-Kownacka, Kazimierz Roszkowski-Sliz Multidisciplinary Respiratory Medicine.2021;[Epub] CrossRef
Advances in the science and treatment of respiratory diseases Jin Hong Chung Yeungnam University Journal of Medicine.2020; 37(4): 251. CrossRef